Blk haploinsufficiency impairs the development, but enhances the functional responses, of MZ B cells

Immunology and Cell Biology

Volumn 90, Issue 6, 2012, Pages 620-629

  Samuelson, Elizabeth M ^a   Laird, Renee M ^a   Maue, Alexander C ^a,b   Rochford, Rosemary ^a   Hayes, Sandra M ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

B cells; B cell receptor; development; kinases; signal transduction

Indexed keywords

B LYMPHOCYTE RECEPTOR; INTERLEUKIN 17; PROTEIN BLK; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; GAMMA DELTA T LYMPHOCYTE; HAPLOINSUFFICIENCY; HEMATOPOIETIC CELL; MARGINAL ZONE B CELL; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, T-INDEPENDENT; AUTOIMMUNITY; B-LYMPHOCYTE SUBSETS; CELL DIFFERENTIATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HAPLOINSUFFICIENCY; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

MUS;

EID: 84863715658     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2011.76     Document Type: Article

References (50)

1. Lowell CA. Src-family kinases: rheostats of immune cell signaling. Mol Immunol 2004; 41: 631-643.
2. Palacios EH, Weiss A. Function of the Src-family kinases, lck and fyn, in T cell development and activation. Oncogene 2004; 23: 7990-8000.
3. Dymecki SM, Niederhuber JE, Desiderio SV. Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells. Science 1990; 247: 332-336.
4. Molina TJ, Kishihara K, Siderovski DP, van Ewijk W, Narendran A, Timms E et al. Profound block in thymocyte development in mice lacking p56lck. Nature 1992; 357: 161-164.
5. Texido G, Su IH, Mecklenbräuker I, Saijo K, Malek SN, Desiderio S et al. The B-cellspecific Src-family kinase Blk is dispensable for B-cell development and activation. Mol Cell Biol 2000; 20: 1227-1233.
6. Borowiec M, Liew CW, Thompson R, Boonyasrisawat W, Hu J, Mlynarski WM et al. Mutations at the BLK locus linked to maturity onset diabetes of the young and b-cell dysfunction. Proc Natl Acad Sci USA 2009; 106: 14460-14465.
7. Laird RM, Laky K, Hayes SM. Unexpected role for the B cell-specific Src family kinase B lymphoid kinase in the development of IL-17-producing gd Tcells. J Immunol 2010; 185: 6518-6527.
8. Cariappa A, Boboila C, Moran ST, Liu H, Shi HN, Pillai S. The recirculating B cell pool contains two functionally distinct, long-lived, posttransitional, follicular B cell populations. J Immunol 2007; 179: 2270-2281.
9. Pillai S, Cariappa A. The follicular versus marginal zone B lymphocyte cell fate decision. Nat Rev Immunol 2009; 9: 767-777.
10. Martin F, Kearney JF. Marginal-zone B cells. Nat Rev Immunol 2002; 2: 323-335.
11. Allman D, Srivastava B, Lindsey RC. Alternative routes to maturity: branch points and pathways for generating follicular and marginal zone B cells. Immunol Rev 2004; 197: 147-160.
12. Allman D, Lindsley RC, DeMuth W, Rudd K, Shinton SA, Hardy RR. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol 2001; 167: 6834-6840.
13. Cariappa A, Liou H-C, Horwitz BH, Pillai S. Nuclear factor kb is required for the development of marginal zone B lymphocytes. J Exp Med 2000; 192: 1175-1182.
14. Guinamard R, Okigaki M, Schlessinger J, Ravetch J. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat Immunol 2000; 1: 31-36.
15. Girkontaite I, Missy K, Sakk V, Harenberg A, Tedford K, Pötzel T et al. Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat Immunol 2001; 2: 855-862.
16. Samardzic T, Marinkovic D, Danzer CP, Gerlach J, Nitschke L, Wirth T. Reduction of marginal zone B cells in CD22-deficient mice. Eur J Immunol 2002; 32: 561-567.
17. Chen Y, Yu M, Podd A, Wen R, Chrzanowska-Wodnicka M, White GC et al. A critical role of Rap1b in B-cell trafficking and marginal zone B-cell development. Blood 2008; 111: 4627-4636.
18. Scheikl T, Reis B, Pfeffer K, Holzmann B, Beer S. Reduced notch activity is associated with an impaired marginal zone B cell development and function in Sly1 mutant mice. Mol Immunol 2009; 46: 969-977.
19. Al-Shami A, Wilkins C, Crisostomo J, Seshasayee D, Martin F, Xu N et al. The adaptor protein Sh2d3c is critical for marginal zone B cell development and function. J Immunol 2010; 185: 327-334.
20. Martin F, Oliver AM, Kearney JF. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 2001; 14: 617-629.
21. Cyster JG, Goodnow CC. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 1995; 2: 13-24.
22. Chan VW, Meng F, Soriano P, DeFranco AL, Lowell CA. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and downregulation. Immunity 1997; 7: 69-81.
23. Inaoki M, Sato S, Weintraub BC, Goodnow CC, Tedder TF. CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J Exp Med 1997; 186: 1923-1931.
24. Wang JH, Avitahl N, Cariappa A, Friedrich C, Ikeda T, Renold A et al. Aiolos regulates B cell activation and maturation to effector state. Immunity 1998; 9: 543-553.
25. O'Keefe TL, Williams GT, Batista FD, Neuberger MS. Deficiency in CD22, a B cellspecific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med 1999; 189: 1307-1313.
26. Lopes-Carvalho T, Kearney JF. Development and selection of marginal zone B cells. Immunol Rev 2004; 197: 192-205.
27. Fairhurst AM, Wandstrat AE, Wakeland EK. Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. Adv Immunol 2006; 92: 1-69.
28. Chen X, Martin F, Forbush KA, Perlmutter RM, Kearney JF. Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int Immunol 1997; 9: 27-41.
29. Grimaldi CM, Michael DJ, Diamond B. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol 2001; 167: 1886-1890.
30. Qian Y, Wang H, Clarke SH. Impaired clearance of apoptotic cells induces the activation of autoreactive anti-Sm marginal zone and B-1 B cells. J Immunol 2004; 172: 625-635.
31. Duan B, Morel L. Role of B-1a cells in autoimmunity. Autoimmun Rev 2006; 5: 403-408.
32. Fletcher CA, Groom JR, Woehl B, Leung H, Mackay C, Mackay F. Development of autoimmune nephritis in genetically asplenic and splenectomized BAFF transgenic mice. J Autoimmun 2011; 36: 125-134.
33. Burkhardt AL, Brunswick M, Bolen JB, Mond JJ. Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases. Proc Natl Acad Sci USA 1991; 88: 7410-7414.
34. Clark MR, Campbell KS, Kazlauskas A, Johnson SA, Hertz M, Potter TA et al. The B cell antigen receptor complex: association of Ig-a and Ig-b with distinct cytoplasmic effectors. Science 1992; 258: 123-126.
35. Lin J, Justement LB. The MB-1/B29 heterodimer couples the B cell antigen receptor to multiple src family protein tyrosine kinases. J Immunol 1992; 149: 1548-1555.
36. Aoki Y, Isselbacher KJ, Cherayil BJ, Pillai S. Tyrosine phosphorylation of Blk and Fyn Src homology 2 domain-binding proteins occur in response to antigen-receptor ligation in B cells and constitutively in pre-B cells. Proc Natl Acad Sci USA 1994; 91: 4204-4208.
37. Malek SN, Desiderio S. SH2 domains of the protein-tyrosine kinases Blk, Lyn, and Fyn(T) bind distinct sets of phosphoproteins from B lymphocytes. J Biol Chem 1993; 268: 22557-22565.
38. Pleiman CM, Clark MR, Timson Gauen LK, Winitz S, Coggeshall KM, Johnson GL et al. Mapping of sites on the Src family protein tyrosine kinases p55blk, p59fyn, and p56lyn which interact with the effector molecular phospholipase C-g2, microtubule-associated protein kinases, GTPase-activating protein, and phosphatidylinositol 3-kinase. Mol Cell Biol 1993; 13: 5877-5887.
39. Kin NW, Crawford DM, Liu J, Behrens TW, Kearney JF. DNA microarray gene expression profile of marginal zone versus follicular B cells and idiotype positive marginal zone B cells before and after immunization with Streptococcus pneumoniae. J Immunol 2008; 180: 6663-6674.
40. Li X, Martin F, Oliver AM, Kearney JF, Carter RH. Antigen receptor proximal signaling in splenic B-2 cell subsets. J Immunol 2001; 166: 3122-3129.
41. Srivastava B, Quinn WJ, Hazard K, Erikson J, Allman D. Characterization of marginal zone B cell precursors. J Exp Med 2005; 202: 1225-1234.
42. Yasuda K, Nagafuku M, Shima T, Okada M, Yagi T, Yamada T et al. Cutting edge: Fyn is essential for tyrosine phosphorylation of Csk-binding protein/phosphoprotein associated with glycolipid-enriched microdomains in lipid rafts in resting T cells. J Immunol 2002; 169: 2813-2817.
43. Cannons JL, Yu LJ, Hill B, Mijares LA, Dombroski D, Nichols KE et al. SAP regulates TH2 differentiation and PKC-y-mediated activation of NF-kB1. Immunity 2004; 21: 693-706.
44. Davidson D, Shi X, Zhang S, Wang H, Nemer M, Ono N et al. Genetic evidence linking SAP, the X-linked lymphoproliferative gene product, to Src-related kinase FynT in TH2 cytokine regulation. Immunity 2004; 21: 707-717.
45. Mamchak AA, Sullivan BM, Hou B, Lee LM, Gilden JK, Krummel MF et al. Normal development and activation but altered cytokine production of Fyn-deficient CD4+ T cells. J Immunol 2008; 181: 5374-5385.
46. Salmond RJ, Filby A, Qureshi I, Caserta S, Zamoyska R. T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance. Immunol Rev 2009; 228: 9-22.
47. Hardy RR. B-1 B cell development. J Immunol 2006; 177: 2749-2754.
48. Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 2008; 358: 900-909.
49. Laird RM, Hayes SM. Roles of the Src tyrosine kinases Lck and Fyn in regulating gdTCR signal strength. PLoS One 2010; 5: e8899.
50. Hayes SM, Li LQ, Love PE. TCR signal strength influences ab/gd lineage fate. Immunity 2005; 22: 583-593.